S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q2 2026

Perceptive Advisors

Period: Q2 2026 Β· Filed: 2026-08-14
View on SEC EDGAR β†—
AUM
$6.66B
Total portfolio value
Positions
109
Reported securities
Top Holding
PRAX
10.2% $681.6M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
PRAXPRAXIS PRECISION MEDICINES I$681.6M10.23%$334.79$366.81+9.6%
10.2%
SYRESPYRE THERAPEUTICS INC$383.5M5.76%$88.78$103.63+16.7%
5.8%
CELCCELCUITY INC$334.5M5.02%$104.62$92.00-12.1%
5.0%
ASNDASCENDIS PHARMA A/S$310.4M4.66%$266.72$248.50-6.8%
4.7%
RYTMRHYTHM PHARMACEUTICALS INC$287.2M4.31%$111.03$115.48+4.0%
4.3%
ROIVROIVANT SCIENCES LTD$286.1M4.30%$35.39$36.20+2.3%
4.3%
RLAYRELAY THERAPEUTICS INC$263.9M3.96%$18.71$19.86+6.2%
4.0%
TVTXTRAVERE THERAPEUTICS INC$213.2M3.20%$56.81$62.14+9.4%
3.2%
KARDIGAN INC$195.6M2.94%β€”β€”
2.9%
NUVLNUVALENT INC$195.2M2.93%β€”β€”
2.9%
EWTXEDGEWISE THERAPEUTICS INC$177.7M2.67%$40.63$44.17+8.7%
2.7%
APGEAPOGEE THERAPEUTICS INC$173.6M2.61%$132.73$134.55+1.4%
2.6%
AMLXAMYLYX PHARMACEUTICALS INC$149.7M2.25%$17.96$21.63+20.4%
2.3%
MGTXMEIRAGTX HLDGS PLC$145.7M2.19%$13.51$13.52+0.1%
2.2%
ORKAORUKA THERAPEUTICS INC$128.0M1.92%$95.17$111.04+16.7%
1.9%
INBXINHIBRX BIOSCIENCES INC$123.0M1.85%$94.75$88.37-6.7%
1.9%
PTGXPROTAGONIST THERAPEUTICS INC$120.4M1.81%$122.58$155.10+26.5%
1.8%
SLDBSOLID BIOSCIENCES INC$119.0M1.79%$9.99$9.20-7.9%
1.8%
ZYMEZYMEWORKS INC$109.3M1.64%$26.14$25.12-3.9%
1.6%
TNGXTANGO THERAPEUTICS INC$105.6M1.58%$31.26$25.60-18.1%
1.6%
IMTXIMMATICS N.V$105.2M1.58%$10.13$9.44-6.8%
1.6%
NRIXNURIX THERAPEUTICS INC$104.8M1.57%$24.26$27.05+11.5%
1.6%
BCRXBIOCRYST PHARMACEUTICALS INC$103.1M1.55%$10.00$9.74-2.6%
1.6%
RVMDREVOLUTION MEDICINES INC$98.8M1.48%$187.28$203.71+8.8%
1.5%
AVLNAVALYN PHARMACEUTICALS INC$88.1M1.32%$32.92$39.25+19.2%
1.3%
MRNAPUTMODERNA INC$70.0M1.05%$70.03$63.32-9.6%
1.1%
DYNDYNE THERAPEUTICS INC$59.7M0.90%$22.21$25.70+15.7%
0.9%
BIIBBIOGEN INC$59.7M0.90%$216.06$209.83-2.9%
0.9%
IMVTIMMUNOVANT INC$52.3M0.79%$38.53$41.82+8.5%
0.8%
UNHUNITEDHEALTH GROUP INC$48.5M0.73%$415.63$401.73-3.3%
0.7%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions (8)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA A/S$310.4M-6.8%
KARDIGAN INC$195.6M
AVLNAVALYN PHARMACEUTICALS INC$88.1M+19.2%
BIIBBIOGEN INC$59.7M-2.9%
UNHUNITEDHEALTH GROUP INC$48.5M-3.3%
XBIPUTSPDR SERIES TRUST$47.5M
CRLCHARLES RIV LABS INTL INC$31.8M
EYPTPUTEYEPOINT INC$28.6M

Exited Positions (8)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA A/S$350.3M-6.8%
CNTACENTESSA PHARMACEUTICALS PLC$208.9M
ENGNENGENE HOLDINGS INC$39.7M
DAWNDAY ONE BIOPHARMACEUTICALS I$37.6M
DRUGBRIGHT MINDS BIOSCIENCES INC$27.6M
BLTEBELITE BIO INC$24.2M
EVMNEVOMMUNE INC$10.3M
NMRANEUMORA THERAPEUTICS INC.$9.9M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ADPTADAPTIVE BIOTECHNOLOGIES COR$24.0M+698.2%
CORTCORCEPT THERAPEUTICS INC$32.6M+696.8%
TNGXTANGO THERAPEUTICS INC$88.7M+317.9%-18.1%
ADGMADAGIO MED HLDGS INC$2.1M+161.2%
SRZNSURROZEN INC$6.4M+119.7%
IRTCIRHYTHM HOLDINGS INC$14.2M+113.1%
RVMDREVOLUTION MEDICINES INC$73.7M+104.0%+8.8%
EOLSEVOLUS INC$11.8M+91.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
GHGUARDANT HEALTH INC$-21.5M-86.2%
ABVXABIVAX SA$-26.8M-77.5%
ADMAADMA BIOLOGICS INC$-3.3M-75.7%
TWSTTWIST BIOSCIENCE CORP$-3.3M-75.5%
AXGNAXOGEN INC$-11.7M-64.5%
CPIXCUMBERLAND PHARMACEUTICALS I$-0.0M-50.8%
VRDNVIRIDIAN THERAPEUTICS INC$-12.2M-50.3%
PHATPHATHOM PHARMACEUTICALS INC$-4.5M-42.5%
← Back to Hedge Funds